SBS

Why is Pfizer's rollout of its anti-COVID pill so slow?

A Pfizer lab technician visually inspects Paxlovid tablet samples in Freiburg, Germany (Suppled - Pfizer).

Source: Supplied: Pfizer

SBS Armenian
View Podcast Series
Download the SBS Audio appAvailable on iOS and Android

Pfizer's COVID-19 treatment pill Paxlovid was the first pill authorized in the U-S to treat coronavirus. But since its approval, there have been questions as to why it takes so long to make. While the time frame to make the pill isn't unusual, some are wondering if supplies will improve.

Share

Latest podcast episodes

Saba Al-Khamisi is a recipient of JobSeeker (SBS Supplied).jpg
Michael Kolokossian.jpeg
Երեւան, Հայաստան
SBS Հայերէն
Follow SBS Armenian
facebook
Download our apps
SBS Audio
iOSAndroid
SBS On Demand
iOSAndroid
Listen to our podcasts
SBS Armenian
Independent news and stories connecting you to life in Australia and Armenian-speaking Australians.
SBS Learn English
Ease into the English language and Australian culture. We make learning English convenient, fun and practical.
Get the latest with our exclusive in-language podcasts on your favourite podcast apps.
Watch on SBS
SBS Armenian News

SBS Armenian News

Watch it onDemand
Watch nowOn Demand
Why is Pfizer's rollout of its anti-COVID pill so slow? | SBS Armenian